Go Symbol Lookup
Loading...

4-Star Biotech Stocks

 Text Size  
Published: Wednesday, 14 May 2008 | 12:03 PM ET
By: Andrew Fisher

Will Muggia likes biotech. Muggia's Touchstone Mid-Cap Growth Fund is up an average of 14.9 percent annually over the last three years -- and even this year, it's up 1.8 percent. So what are the 4-star portfolio manager's picks?

Recommendations:

Muggia likes Celgene, "one of the fastest-growing biotechnology companies in the world today. He expects the firm to have 40 percent earnings growth.

He praises Elan Pharmaceuticals for its auto-immune and Alzheimer's medicines. He says the latter illness has barely begun to be addressed medically, with plenty of potential left.

CNBC.com Web Exclusive:
(Not found on TV)

For CNBC.com readers, Muggia also recommends Chesapeake Energy.

Disclosures:

Muggia personally owns both Celgene and Elan, and the stocks are the largest holdings in his fund.

Disclaimer

 Print
Will Muggia likes biotech. He's co-portfolio manager of the Touchstone Mid-Cap Growth Fund, which is up an average of 14.9 percent annually over the last three years -- and even this year, it's up 1.8 percent. So what are the 4-star portfolio manager's picks?
  Price   Change %Change
CELG ---
CHK ---
DRX ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured